Association of alkaptonuria and low dose nitisinone therapy with cataract formation in a large cohort of patients
Homogentisic acid (HGA) lowering, disease modifying off-label nitisinone therapy has been used in the United Kingdom National Alkaptonuria Centre (NAC) since 2012. This study evaluated the serendipitous observation of cataract in a large cohort of patients with the very rare disease alkaptonuria (AK...
Main Authors: | Ahmad, M.S.Z (Author), Ahmed, M. (Author), Borgia, A. (Author), Kaye, S. (Author), Khedr, M. (Author), Madden, A. (Author), Ranganath, L.R (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
John Wiley and Sons Inc
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Vitiligo, alkaptonuria, and nitisinone—A report of three families and review of the literature
by: Lakshminarayan Ranganath, et al.
Published: (2021-09-01) -
Evaluation of the serum metabolome of patients with alkaptonuria before and after two years of treatment with nitisinone using LC‐QTOF‐MS
by: Andrew S. Davison, et al.
Published: (2019-07-01) -
Reversal of ochronotic pigmentation in alkaptonuria following nitisinone therapy: Analysis of data from the United Kingdom National Alkaptonuria Centre
by: Lakshminarayan R. Ranganath, et al.
Published: (2020-09-01) -
Preventive use of nitisinone in alkaptonuria
by: Bruce H. R. Wolffenbuttel, et al.
Published: (2021-08-01) -
Fatal acute haemolysis and methaemoglobinaemia in a man with renal failure and Alkaptonuria – Is nitisinone the solution?
by: A.S. Davison, et al.
Published: (2020-06-01)